SV2009003235A - Triazoles biciclicos como moduladores de la proteina cinasa ref. x-18476m - Google Patents
Triazoles biciclicos como moduladores de la proteina cinasa ref. x-18476mInfo
- Publication number
- SV2009003235A SV2009003235A SV2009003235A SV2009003235A SV2009003235A SV 2009003235 A SV2009003235 A SV 2009003235A SV 2009003235 A SV2009003235 A SV 2009003235A SV 2009003235 A SV2009003235 A SV 2009003235A SV 2009003235 A SV2009003235 A SV 2009003235A
- Authority
- SV
- El Salvador
- Prior art keywords
- met
- bicycle
- compounds
- cinasa
- triazols
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE HA DESCUBIERTO QUE LOS COMPUESTOS TRIAZOLE BICICLICOS DE LA PRESENTE DIVULGACIÓN SE PODRÍAN UTILIZAR PARA MODULAR LA ACTIVIDAD DE LA CINASA Y PARA TRATAR ENFERMEDADES MEDIADAS POR LA ACTIVIDAD DE LA MISMA. EN PARTICULAR, LOS COMPUESTOS DE LA PRESENTE DIVULGACIÓN PUEDEN UTILIZARSE PARA MODULAR O INHIBIR LAS TIROSINA CINASAS, O AMBAR INCLUSIVE EL MET. ADEMÁS, LOS COMPUESTOS DE LA PRESENTE DIVULGACIÓN PUEDEN UTILIZARSE PARA REDUCIR O INHIBIR LA ACTIVIDAD DE LA CINASA DE MET EN UNA CÉLULA O SUJETO, Y MODULAR LA MANIFESTACIÓN MET EN UNA CELULA O SUJETO. LOS COMPUESTOS DIVULGADOS SON TAMBIÉN MUY ÚTILES PARA IMPEDIR O TRATAR, UN TRASTORNO PROLIFERATIVO DE CÉLULAS O UN TRASTORNO RELACIONADO CON MET EN UN SUJETO.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86255206P | 2006-10-23 | 2006-10-23 | |
US87030906P | 2006-12-15 | 2006-12-15 | |
US91376607P | 2007-04-24 | 2007-04-24 | |
US95284007P | 2007-07-30 | 2007-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2009003235A true SV2009003235A (es) | 2009-10-15 |
Family
ID=38956385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2009003235A SV2009003235A (es) | 2006-10-23 | 2009-04-23 | Triazoles biciclicos como moduladores de la proteina cinasa ref. x-18476m |
Country Status (25)
Country | Link |
---|---|
US (1) | US8507489B2 (es) |
EP (1) | EP2084162B1 (es) |
JP (1) | JP5378222B2 (es) |
KR (1) | KR20090071612A (es) |
AR (1) | AR063520A1 (es) |
AU (1) | AU2007309149C1 (es) |
BR (1) | BRPI0717320A2 (es) |
CA (1) | CA2667428A1 (es) |
CO (1) | CO6190620A2 (es) |
CR (1) | CR10803A (es) |
DK (1) | DK2084162T3 (es) |
EA (1) | EA200970403A1 (es) |
ES (1) | ES2393130T3 (es) |
IL (1) | IL197958A0 (es) |
MA (1) | MA30871B1 (es) |
MX (1) | MX2009004059A (es) |
NO (1) | NO20091618L (es) |
NZ (1) | NZ575336A (es) |
PE (1) | PE20080893A1 (es) |
PL (1) | PL2084162T3 (es) |
PT (1) | PT2084162E (es) |
SV (1) | SV2009003235A (es) |
TN (1) | TN2009000142A1 (es) |
TW (1) | TW200835492A (es) |
WO (1) | WO2008051808A2 (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PA8792501A1 (es) * | 2007-08-09 | 2009-04-23 | Sanofi Aventis | Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol,su procedimiento de preparación,su aplicación como medicamentos,composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met. |
TWI365185B (en) | 2008-07-24 | 2012-06-01 | Lilly Co Eli | Amidophenoxyindazoles useful as inhibitors of c-met |
UY32049A (es) | 2008-08-14 | 2010-03-26 | Takeda Pharmaceutical | Inhibidores de cmet |
EP2165710A1 (en) * | 2008-09-19 | 2010-03-24 | Institut Curie | Tyrosine kinase receptor Tyro3 as a therapeutic target in the treatment of a bladder tumor |
WO2010059771A1 (en) | 2008-11-20 | 2010-05-27 | Osi Pharmaceuticals, Inc. | Substituted pyrrolo[2,3-b]-pyridines and-pyrazines |
FR2941951B1 (fr) * | 2009-02-06 | 2011-04-01 | Sanofi Aventis | Derives de 6-(6-nh-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met. |
FR2941952B1 (fr) * | 2009-02-06 | 2011-04-01 | Sanofi Aventis | Derives de 6-(6-substitue-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles et 5-fluoro-benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met. |
FR2941950B1 (fr) * | 2009-02-06 | 2011-04-01 | Sanofi Aventis | Derives de 6-(6-o-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met. |
FR2941949B1 (fr) * | 2009-02-06 | 2011-04-01 | Sanofi Aventis | Derives de 6-(6-o-cycloalkyl ou 6-nh-cycloalkyl- triazolopyridazine-sulfanyl)benzothiazoles et benzimidazoles preparation, application comme medicaments et utilisation comme inhibiteurs de met. |
CA2770873A1 (en) | 2009-08-12 | 2011-02-17 | Novartis Ag | Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation |
EP2467383A1 (en) | 2009-08-20 | 2012-06-27 | Novartis AG | Heterocyclic oxime compounds |
RS61281B1 (sr) | 2009-12-31 | 2021-02-26 | Hutchison Medipharma Ltd | Sintetički intermedijer koristan u pripremi triazolopiridinskih c-met inhibitora |
JP2013526570A (ja) | 2010-05-14 | 2013-06-24 | オーエスアイ・ファーマシューティカルズ,エルエルシー | 縮合二環式キナーゼ阻害剤 |
AR081039A1 (es) | 2010-05-14 | 2012-05-30 | Osi Pharmaceuticals Llc | Inhibidores biciclicos fusionados de quinasa |
AR085183A1 (es) * | 2010-07-30 | 2013-09-18 | Lilly Co Eli | Compuesto 6-(1-metil-1h-pirazol-4-il)-3-(2-metil-2h-indazol-5-iltio)-[1,2,4]triazol[4,3-b]piridazina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar cancer |
UY33549A (es) * | 2010-08-10 | 2012-01-31 | Glaxo Group Ltd | Quinolil aminas como agentes inhibidores de las quinasas |
WO2012042421A1 (en) | 2010-09-29 | 2012-04-05 | Pfizer Inc. | Method of treating abnormal cell growth |
CN102532141A (zh) | 2010-12-08 | 2012-07-04 | 中国科学院上海药物研究所 | [1,2,4]三唑并[4,3-b][1,2,4]三嗪类化合物、其制备方法和用途 |
EP3210984B1 (en) | 2011-01-11 | 2019-06-19 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
EP2673277A1 (en) | 2011-02-10 | 2013-12-18 | Novartis AG | [1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase |
CN103459396B (zh) * | 2011-02-10 | 2015-08-19 | 诺瓦提斯公司 | 作为c-Met酪氨酸激酶抑制剂的[1,2,4]三唑并[4,3-b]哒嗪化合物 |
WO2012158658A1 (en) | 2011-05-16 | 2012-11-22 | OSI Pharmaceuticals, LLC | Fused bicyclic kinase inhibitors |
CN103958509B (zh) * | 2011-09-15 | 2015-12-23 | 诺华股份有限公司 | 作为酪氨酸激酶抑制剂的6-取代的3-(喹啉-6-基硫代)-[1,2,4]三唑并[4,3-a]吡啶化合物 |
ES2691650T3 (es) | 2011-09-15 | 2018-11-28 | Novartis Ag | 3-(quinolin-6-il-tio)-[1,2,4]-triazolo-[4,3-a]-piridinas 6-sustituidas como inhibidores de tirosina quinasa c-Met |
JP2015512447A (ja) | 2012-04-03 | 2015-04-27 | ノバルティス アーゲー | チロシンキナーゼ阻害薬の組合せおよびその使用 |
RU2660354C2 (ru) | 2012-04-03 | 2018-07-05 | Новартис Аг | Комбинированные продукты, содержащие ингибиторы тирозинкиназ, и их применение |
CN103122000B (zh) * | 2012-09-03 | 2013-12-25 | 中美冠科生物技术(太仓)有限公司 | 用作抗肿瘤药物的高选择性的c-Met激酶抑制剂 |
WO2014089904A1 (en) * | 2012-12-10 | 2014-06-19 | Abbvie Inc. | Triazinone compounds |
WO2014164200A1 (en) | 2013-03-13 | 2014-10-09 | Avon Products, Inc | Tyrosinase inhibitors |
WO2014158943A1 (en) * | 2013-03-13 | 2014-10-02 | Avon Products, Inc | Tyrosinase inhibitors |
WO2014164195A1 (en) | 2013-03-13 | 2014-10-09 | Avon Products, Inc | Tyrosinase inhibitors |
EP3404032A3 (en) * | 2013-03-13 | 2019-03-13 | F. Hoffmann-La Roche AG | Process for making benzoxazepin compounds |
WO2014174478A1 (en) | 2013-04-26 | 2014-10-30 | Novartis Ag | Pharmaceutical combinations of a pkc inhibitor and a c-met receptor tyrosine kinase inhibitor |
CA2910367C (en) * | 2013-05-10 | 2021-07-20 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | [1,2,4] triazol [4,3-a] pyridine derivate, preparation method therefor or medical application thereof |
WO2017049711A1 (zh) | 2015-09-24 | 2017-03-30 | 上海海聚生物科技有限公司 | 喹啉类衍生物、其药物组合物、制备方法及应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5604091A (en) | 1984-03-01 | 1997-02-18 | Microgenics Corporation | Methods for protein binding enzyme complementation |
JPS60194443A (ja) * | 1984-03-16 | 1985-10-02 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
EP0228061A3 (en) * | 1985-12-23 | 1988-12-14 | Takeda Chemical Industries, Ltd. | Cephem compounds |
JPS62228086A (ja) * | 1985-12-23 | 1987-10-06 | Takeda Chem Ind Ltd | セフエム化合物 |
GB9918035D0 (en) | 1999-07-30 | 1999-09-29 | Novartis Ag | Organic compounds |
WO2002083139A1 (en) | 2001-04-10 | 2002-10-24 | Merck & Co., Inc. | Inhibitors of akt activity |
US6960584B2 (en) * | 2001-04-10 | 2005-11-01 | Merck & Co., Inc. | Inhibitors of Akt activity |
US20030229453A1 (en) | 2002-04-09 | 2003-12-11 | Antonysamy Stephen Suresh | Crystals and structures of PAK4KD kinase PAK4KD |
MXPA05006478A (es) * | 2002-12-18 | 2005-09-08 | Vertex Pharma | Triazolopiridazinas como inhibidores de proteinas cinasas. |
US7122548B2 (en) * | 2003-07-02 | 2006-10-17 | Sugen, Inc. | Triazolotriazine compounds and uses thereof |
WO2006015124A2 (en) * | 2004-07-27 | 2006-02-09 | Sgx Pharmaceuticals, Inc. | Fused ring heterocycle kinase modulators |
ES2355923T3 (es) | 2004-08-26 | 2011-04-01 | Pfizer, Inc. | Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa. |
PL383491A1 (pl) | 2004-12-27 | 2008-03-17 | Alcon, Inc. | Analogii aminopirazyny do leczenia jaskry oraz innych chorób i stanów związanych z kinazą RHO |
-
2007
- 2007-10-18 PL PL07844414T patent/PL2084162T3/pl unknown
- 2007-10-18 NZ NZ575336A patent/NZ575336A/en not_active IP Right Cessation
- 2007-10-18 ES ES07844414T patent/ES2393130T3/es active Active
- 2007-10-18 MX MX2009004059A patent/MX2009004059A/es active IP Right Grant
- 2007-10-18 PT PT07844414T patent/PT2084162E/pt unknown
- 2007-10-18 JP JP2009533541A patent/JP5378222B2/ja not_active Expired - Fee Related
- 2007-10-18 DK DK07844414.8T patent/DK2084162T3/da active
- 2007-10-18 WO PCT/US2007/081841 patent/WO2008051808A2/en active Application Filing
- 2007-10-18 EA EA200970403A patent/EA200970403A1/ru unknown
- 2007-10-18 BR BRPI0717320-2A2A patent/BRPI0717320A2/pt not_active IP Right Cessation
- 2007-10-18 US US12/442,566 patent/US8507489B2/en not_active Expired - Fee Related
- 2007-10-18 EP EP07844414A patent/EP2084162B1/en active Active
- 2007-10-18 AU AU2007309149A patent/AU2007309149C1/en not_active Ceased
- 2007-10-18 CA CA002667428A patent/CA2667428A1/en not_active Abandoned
- 2007-10-18 KR KR1020097008200A patent/KR20090071612A/ko active IP Right Grant
- 2007-10-22 TW TW096139480A patent/TW200835492A/zh unknown
- 2007-10-23 PE PE2007001437A patent/PE20080893A1/es not_active Application Discontinuation
- 2007-10-23 AR ARP070104680A patent/AR063520A1/es not_active Application Discontinuation
-
2009
- 2009-04-05 IL IL197958A patent/IL197958A0/en unknown
- 2009-04-15 TN TNP2009000142A patent/TN2009000142A1/fr unknown
- 2009-04-22 CO CO09040677A patent/CO6190620A2/es not_active Application Discontinuation
- 2009-04-23 SV SV2009003235A patent/SV2009003235A/es not_active Application Discontinuation
- 2009-04-23 NO NO20091618A patent/NO20091618L/no not_active Application Discontinuation
- 2009-05-07 MA MA31849A patent/MA30871B1/fr unknown
- 2009-05-19 CR CR10803A patent/CR10803A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US8507489B2 (en) | 2013-08-13 |
TN2009000142A1 (en) | 2010-10-18 |
PT2084162E (pt) | 2012-10-09 |
MX2009004059A (es) | 2009-04-27 |
BRPI0717320A2 (pt) | 2013-10-22 |
IL197958A0 (en) | 2009-12-24 |
CR10803A (es) | 2009-06-16 |
EP2084162B1 (en) | 2012-09-12 |
PE20080893A1 (es) | 2008-08-26 |
JP5378222B2 (ja) | 2013-12-25 |
NZ575336A (en) | 2012-04-27 |
CO6190620A2 (es) | 2010-08-19 |
MA30871B1 (fr) | 2009-11-02 |
WO2008051808A2 (en) | 2008-05-02 |
ES2393130T3 (es) | 2012-12-18 |
EA200970403A1 (ru) | 2009-10-30 |
KR20090071612A (ko) | 2009-07-01 |
AU2007309149B2 (en) | 2012-09-06 |
US20090258855A1 (en) | 2009-10-15 |
CA2667428A1 (en) | 2008-05-02 |
JP2010507578A (ja) | 2010-03-11 |
AU2007309149A1 (en) | 2008-05-02 |
AR063520A1 (es) | 2009-01-28 |
EP2084162A2 (en) | 2009-08-05 |
WO2008051808A3 (en) | 2008-07-24 |
AU2007309149C1 (en) | 2013-04-04 |
PL2084162T3 (pl) | 2013-01-31 |
DK2084162T3 (da) | 2012-10-01 |
NO20091618L (no) | 2009-05-22 |
TW200835492A (en) | 2008-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2009003235A (es) | Triazoles biciclicos como moduladores de la proteina cinasa ref. x-18476m | |
CY1121144T1 (el) | Ετεροκυκλικες ενωσεις και χρησεις αυτων | |
CU20080223A7 (es) | Compuestos de pirrolo-pirimidina y sus usos | |
CR11264A (es) | Compuestos de 5-(4-halo-alcoxi)-fenil)-pirimidin-2-amina y composiciones como inhibidores de cinasa | |
CL2010001538A1 (es) | Compuestos derivados de pirazolo-quinazolina sustituidos, moduladores de la actividad de las proteinas quinasas; composicion farmaceutica; y su uso para el tratamiento del cancer, o un trastorno proliferativo celular. | |
SV2008002963A (es) | Triazolopiridazinas como moduladores de tirosina cinasa referencia cruzada con solicitudes relacionadas ref. prd2584sv | |
CL2011000973A1 (es) | Compuestos derivados de pirazolo [1,5-a]pirimidina3-cabroxamida; composicion farmaceutica que los comprende, y uso para tratar o disminuir la gravedad de una enfermedad o condicion que responde a la inhibicion de la actividad de una jak quinasa. | |
CR10566A (es) | Compuestos heterociclicos adecuados para el tratamiento de enfermedades relacionadas con nivel elevado de lipidos | |
CL2011003082A1 (es) | Compuestos derivados de [1,2,4]triazolo[1,5-a]piridina, inhibidores de jak2 o fak; composiciones farmaceuticas que los comprenden; y su uso para el tratamiento de una enfermedad hiperproliferativa. | |
GT200900146A (es) | Inhibidores de la actividad de la akt | |
CR9677A (es) | Derivados de pirrolo(2,3-b) piridina como inhibidores de proteina cinasa | |
ECSP10010695A (es) | Compuestos de piridina | |
ECSP078013A (es) | Inhibidores heterocíclicos de mek y métodos de uso de ellos | |
CR11430A (es) | 4-pirazolil-n-arilpirimidin-2-aminas y 4-pirazolil-n-heteroarilpirimidin-2-aminas como inhibidores de cinasas janus | |
CL2011000488A1 (es) | Compuestos derivados de pirazolo-pirimidinas sustituidas; composicion y combinacion farmaceutica que los comprenden; y su uso como inhibidores de pde9 para el tratamiento, alivio y/o prevencion de deterioros cognitivos relacionados con la percepcion, alzheimer,trastornos del sueño, trastorno bipolar, diabetes mellitus. | |
MX2010006203A (es) | Derivados de pirazol y uso de los mismos como inhibidores de cinasas dependientes de ciclina. | |
SV2011003786A (es) | Compuestos quimicos 251 | |
CR10860A (es) | Compuestos y metodos para modulacion de cinasas, e indicaciones para ello | |
BRPI0803374A2 (pt) | compostos polihidróxi como agentes de extinção de polimerização | |
ECSP088906A (es) | PIRAZOLO 1,5-a PIRIMIDINAS | |
CL2011000489A1 (es) | Compuestos derivados de pirimido[5,4-d]pirimidina, los cuales actuan como inhibidores de tirosina-quinasas; y composiciones farmaceuticas que los comprenden, utiles en el tratamiento de enfermedades que se caracterizan por una proliferacion celular excesiva o anomala | |
UY32291A (es) | Inhibidores de quinasa con perfiles de seguridad cyp mejorados | |
GT200600248A (es) | Aminopirimidinas como moduladores de quinasas | |
CL2008001560A1 (es) | Compuestos derivados de heterociclo de nitrogenado, moduladores de gamma secretasa; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades neurodegenerativas como el alzheimer, sindrome de down; kit farmaceutico. | |
NI200700313A (es) | Aminopirimidinas como moduladores de la cinasa . |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Lapse |